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Subintimal angioplasty of chronic total occlusion
in iliac arteries: A safe and durable option
Brian L. Chen, MD, Harry R. Holt, BS, Jarrod D. Day, MD, Christopher L. Stout, MD,
Gordon K. Stokes, MD, and Jean M. Panneton, MD, Norfolk, Va
Background: Traditionally, aortobifemoral bypass has been the intervention of choice for iliac artery chronic total
occlusions (CTOs). However, it is associated with significant morbidity and mortality, limiting its use in high-risk
patients. To reduce procedural risk, subintimal angioplasty (SIA) for femoropopliteal CTO has been utilized by many,
but few have extended this endovascular technique to treating iliac artery CTOs. We present our experience with 101
successful SIAs for iliac artery CTOs.
Methods: A retrospective review of consecutive patients with iliac artery CTOs treated with subintimal angioplasty from
June 2000 to January 2009 was completed. Demographic and risk factor data were obtained, along with procedural data.
Primary and secondary patency, survival, freedom from claudication, and limb salvage rates were determined by
Kaplan-Meier survival analysis. Univariate and multivariate analyses were completed to identify factors adversely
affecting primary patency.
Results:One hundred twenty patients underwent an attempted SIA of an iliac artery CTO, and 101 iliac artery CTOs were
successfully treated, giving a technical success rate of 84%. Technical failure was due to the inability to re-enter the lumen
in all cases. Indications for intervention were lifestyle-altering claudication in 64 patients (63%) and critical limb ischemia
(CLI), in 37 (37%). Eighty-five patients underwent percutaneous SIA, while 11 patients underwent a combined SIA with
surgical outflow procedure. Lesions were classified as TransAtlantic InterSociety Consensus (TASC) B, 39 (39%); TASC
C, 27 (27%); and TASC D, 35 (35%). In 82 (81%) lesions, stents were deployed with an average of 1.2 (range, 0-3) stents
utilized. A re-entry device was used in 14 (14%) lesions. Major complication rate was 3.0%, with a 30-day mortality rate
of 1.0%. Primary and secondary patency rates at 1, 2, and 3 years were 86% and 94%, 76% and 92%, and 68% and 80%,
respectively. Survival rate was 67% at 5 years, reflecting the poor health of this cohort. Limb salvage for CLI patients at
1 and 5 years was 97% and 95%, respectively. Freedom from claudication at 1 and 3 years was 89% and 73%. Univariate
analysis identified hyperlipidemia, coronary artery disease, and prior surgical bypass in treated limb as factors for loss of
primary patency; however, on multivariate analysis, no factors remained statistically significant.
Conclusion: This study demonstrates that SIA of iliac CTOs is feasible and can be performed safely and effectively, even
in high-risk patients. Excellent patency and limb salvage rates can be achieved. In our experience, the safety and durability
of SIA makes it an attractive first-line therapy for iliac artery occlusive disease. ( J Vasc Surg 2011;53:367-73.)
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nTherapeutic options for chronic total occlusions (CTOs)
of iliac arteries have evolved during the past two decades.
Although aortobifemoral bypass is still considered the gold
standard for treatment of iliac artery CTOs, the procedure
carries a mortality rate of 4.4% and a major complication
rate of 12.1%.1 As the population accumulates more co-
morbidities, fewer patients will be considered an acceptable
risk for open revascularization.
As endovascular techniques have matured, these tech-
niques have been applied to increasingly sicker patients.
Kashyap published results for intraluminal endovascular
interventions for aortoiliac occlusive disease with a primary
patency rate of 74% at 3 years and a secondary patency of
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doi:10.1016/j.jvs.2010.08.0735% at 3 years.2 While the bulk of the literature details the
se of intraluminal endovascular techniques for iliac steno-
es, there has been a paucity of studies addressing iliac artery
TO.Most who have attempted crossing iliac artery CTOs
n an intraluminal fashion have experience with inadver-
ently causing a subintimal dissection. The next logical
uestion from this experience is: Can subintimal angio-
lasty (SIA) be used for treatment of iliac artery CTOs?
Developed in the United Kingdom in 1989, SIA has
ained acceptance throughout Europe.3 Theoretically, it
ircumvents the occluded lumen by creating a new channel
ithin a subintimal plane. SIA can treat longer femoropop-
iteal artery occlusions than intraluminal angioplasty and is
lso considered to be safer than open surgery.4 A meta-
nalysis of SIA revealed a technical success rate of 86%, with
1-year primary patency rate of 56% and a limb salvage rate
f 89%.5 While this study analyzed 37 studies, only two of
hese included iliac artery interventions for a total of 79
atients. These results are similar to our published experi-
nce with infrainguinal SIA, with a 1-year primary patency
f 45% and limb salvage rate of 88%.6 This article also did
ot focus on iliac artery CTOs.
To date, there has not been a published series of iliac
rtery CTOs managed exclusively with SIA. Based on our
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February 2011368 Chen et alexperience with improved safety with SIA of femoropopli-
teal lesions, we hypothesized this technique could be ap-
plied to iliac artery CTOs to obtain a similar improvement
in morbidity and mortality. It is the purpose of this study to
determine the safety and durability of the technique in
dealing with iliac artery CTOs.
METHODS
Patients. After approval of the Institutional Review
Board, a retrospective review of patients who underwent
SIA for an iliac artery CTO from June 2000 to January
2009 was performed. Patient hospital and clinic records
along with angiograms were reviewed. Patient demograph-
ics, risk factors, indications for the procedure, procedural
details, preoperative and postoperative vascular studies, and
outcome data such as primary and secondary patencies,
periprocedural complications, and mortality were collected
in a database for analysis. Procedural details on secondary
and tertiary interventions were also recorded. TransAtlantic
InterSociety Consensus (TASC) II classification of treated
lesions were determined intraoperatively or after review of
angiographic studies under the direct supervision of the
senior author or primary surgeon.7
Preoperative noninvasive evaluation. In general, an-
kle-brachial indices (ABIs) with waveform analysis were
obtained to identify patients with aortoiliac occlusive dis-
ease. Those with studies consistent with such had aortoiliac
duplex imaging to identify lesions and the presence of iliac
artery aneurysms. The location of lesions determined opti-
mal arterial access and iliac artery aneurysm was an absolute
contraindication to SIA. Computed tomographic angiog-
raphy (CTA) was not routinely utilized, except when
screening for additional pathology.
Operative technique. Most SIA was performed in the
angiographic suite, although those cases also requiring an
immediate outflow procedure were completed in the oper-
ating room. The need for combined open surgery and SIA
was determined by diagnostic angiogram. Patients with
femoral lesions amendable to endarterectomy or those with
need for immediate outflow revascularization were sched-
uled for a combined procedure.
Arterial access was obtained through femoral or bra-
chial arteries. Not infrequently, bilateral simultaneous ac-
cesses were necessary. In most cases, a hydrophilic stiff or
soft-tip 0.035-inch Glidewire (Terumo Medical Corpora-
tion, Somerset, NJ) was used in combination with an
angled catheter such as the Glidecath (Terumo Medical
Corporation) or Berenstein (AngioDynamics, Latham,
NY). The catheter was used to engage the lesion and direct
the wire into the subintimal plane. The Quick-Cross (Spec-
tranetics Corporation, Colorado Springs, Colo) catheter
was also used, mainly to give more columnar support for
the wire in tight lesions.
Depending on the preferential dissection direction of
the wire, SIA was performed in either an antegrade or
retrograde direction. In a few cases, a 6-10 mm angioplasty
balloon was used to create dissections in iliac arteries to
facilitate subintimal dissection. Entry into the subintimal ypace was determined by the fluoroscopic behavior of the
issection wire and the significantly increased tactile resis-
ance during dissection. If there were any questions of
ubintimal presence, a 1-2 mL injection of contrast was
ompleted. As the subintimal space is not well vascularized,
he dye remains in place when re-entry has not been
chieved. In all cases, re-entry into the true lumen was
erified angiographically prior to performing a balloon
ngioplasty. In difficult re-entry cases, re-entry devices such
s the Outback (Cordis Corporation, Warren, NJ) and the
ioneer (Medtronic, Santa Rosa, Calif) were used.
After balloon angioplasty of the subintimal channel,
elective stenting was utilized at the judgment of the sur-
eon based on criteria previously published in our infrain-
uinal SIA experience.8 Type and number of stents used
ere also at the judgment of the individual surgeon. When
ilateral common iliac artery lesions were treated, a kissing-
alloon technique was utilized, otherwise, a unilateral bal-
oon was utilized. Completion angiograms were performed
n all cases. Due to concerns with rupture during SIA, an
ppropriately sized covered stent was available if extravasa-
ion was identified during the completion angiogram.
Anticoagulation was not routinely given preoperatively
r postoperatively. Heparin was given routinely after place-
ent of a working sheath and prior to dissection of lesions.
nless already on Plavix, newly stented patients were
oaded on 300 mg and continued on 75 mg daily for 1
onth. Double antiplatelet regimens were not routinely
rescribed.
Definitions. Primary and secondary patencies were
efined in compliance with the Society for Vascular Sur-
ery® reporting standard for lower extremity ischemia.9
hese patencies were based on operative reports including
econdary and tertiary procedures, both invasive and non-
nvasive vascular studies, and clinical status. Evidence of loss
f patency included loss of pulses if present after the inter-
ention, a duplex ultrasound study demonstrating occlu-
ion or velocities300 cm/s and having a lesion velocity to
djacent segment velocity ratio 3.5, angiographic evi-
ence of 50% restenosis or reocclusion, or intraoperative
vidence of occlusion. Technical success was defined as SIA
ith or without stenting demonstrating 30% residual
tenosis and no flow-limiting lesion on completion angio-
ram. Symptomatic improvement was defined as subjective
mprovement in claudication symptoms in those patients
ith lifestyle-altering claudication.
Clinical-evaluation. Clinical follow-up was typically
t 1 month, 6 months, 12 months, and then every 6 to 12
onths thereafter. On follow-up, ABI with waveform anal-
sis and aortoiliac duplex ultrasound studies were per-
ormed.
Statistics. Continuous data were expressed as mean
tandard deviation. P  .05 was considered to be statisti-
ally significant. Technical failures were not included in the
tatistical analysis as SIA had not been performed. Primary
nd secondary patencies, limb salvage, and freedom from
laudication were analyzed by Kaplan-Meier survival anal-
sis on an individual lesion basis. Survival was analyzed by
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Volume 53, Number 2 Chen et al 369Kaplan-Meier survival analysis on an individual patient ba-
sis. Multivariate analysis was performed using Cox propor-
tional hazard regression. SPSS 17.0 (SPSS, Chicago, Ill)
was used for all statistical analysis.
RESULTS
Between June 2000 and January 2009, approximately
2000 patients underwent iliac artery angioplasty. Of these,
118 patients were identified as having undergone at-
tempted SIA for iliac artery CTO. Two patients were
excluded from analysis due to immediate lost to follow-up.
The remaining 116 study patients were found to have a
total of 121 iliac artery CTOs during angiography. The 15
vascular surgeons in this study obtained a technical success
rate of 83.5% (101 iliac artery CTOs). Technical failure in
20 patients was due to inability to achieve re-entry into the
true lumen. Reviewing the outcomes of these 20 patients
revealed that 2 were lost to follow-up, 2 refused recom-
mended surgical intervention and had no subsequent inter-
vention, and 16 underwent surgical revascularization, con-
sisting of iliofemoral endarterectomy, femoral-to-femoral
bypass, and unilateral iliofemoral bypass.
The 96 patients undergoing successful iliac artery SIA
had an average age of 63.8  10.1 years old, with a
male-to-female ratio of roughly 3:2 (55:41). Ethnicity of
these patients was 62 (64.6%) Caucasian, 32 (33.0%) Afri-
can American, 1 (1.0%) Hispanic, and 1 (1.0%) other
ethnicity. The atherosclerotic risk factor profile for these
patients is tabulated in Table I. This population demon-
strated a marked prevalence of coronary artery disease
(57.3%), diabetes (39.6%), and end-stage renal disease
(13.5%). Other comorbidities tabulated included chronic ob-
structive pulmonary disease (11.5%) and obesity (36.5%).
Additionally, prior vascular bypass operations had previously
been performed in 10.4% of treated limbs.
Indications for iliac artery SIA were lifestyle-altering
claudication, 64 (63.3%), and critical limb ischemia, con-
sisting of 19 (18.8%) gangrene and 18 (17.8%) rest pain.
Seventeen (16.8%) patients were considered to be at pro-
hibitive risk for open surgery. This determination was based
on preoperative evaluation of these patients’ comorbidities
and the surgeon’s judgment. Eleven lesions were treated
Table I. Patient risk factors and comorbidities in 96
successfully treated patients
Variable n (%)
Hypertension 77 (80.2%)
Hypercholesterolemia 73 (76.0%)
Diabetes mellitus 38 (39.6%)
End-stage renal disease 13 (13.5%)
Coronary artery disease 55 (57.3%)
Previous smoker 31 (32.3%)
Current smoker 53 (55.2%)
Prior surgical bypass in treated limb 10 (10.4%)
Chronic obstructive pulmonary disease 11 (11.5%)
Obesity 35 (36.5%)with a combined approach of SIA and surgical outflow aperation, including common femoral artery endarterec-
omy with patch angioplasty or distal bypass. The remain-
ng 90 lesions were treated with percutaneous SIA alone.
hese include five patients who also had contralateral iliac
rtery CTOs treated with SIA.
Arterial access was preferentially via the femoral arter-
es, 98 (97.0%), with only 3 (3.0%) brachial artery accesses.
he details of vessel segments treated are listed in Table II,
ith their TASC II classifications listed in Table III. Cross-
ng the CTO required an antegrade approach via a con-
ralateral access in 52 (51.5%) lesions and a retrograde
pproach in 49 (48.5%). In treating bilateral common iliac
rtery occlusions, the kissing-balloon technique was uti-
ized in 61 (60.4%) lesions, the remaining 40 (39.6%) had a
nilateral balloon used. Some of these bilateral lesions were
reated with combined intraluminal and subintimal tech-
iques. Stents were deployed selectively in 82 (81.2%)
esions. A total of 119 stents were deployed, with a single
tent in 49 (48.5%) lesions, 2 stents in 29 (28.7%) lesions,
nd 3 stents in 4 (4.0%) lesions. A re-entry device such as
he Outback or Pioneer, was used in 14 (13.9%) lesions.
A 30-day procedural mortality rate of 1.0% (1) was
chieved with a 30-day overall complication rate of 8.9%
9) occurred during this study and a major complication
ate of 3.0% (3). These procedural complications are listed
n Table IV. The majority of these complications did not
equire operative intervention. In one case, a presumed
etroperitoneal bleed was explored, but no injury to the
reated iliac artery was identified. The one death in this
eries occurred during a rupture of an external iliac artery.
he injury was identified immediately after re-angioplasty
f a partially deployed stent and was treated with a covered
tent. While the patient remained hemodynamically stable
hroughout the remainder of his case, he went into cardiac
able II. Distribution of 101 iliac artery chronic total
cclusions
essels involved n (%)
IA 40 (39.6%)
ombined CIA and EIA 24 (23.8%)
ombined CIA, EIA, and SFA 5 (5.0%)
IA 24 (23.8%)
ombined EIA and SFA 5 (5.0%)
ombined EIA, SFA, and popliteal artery 3 (3.0%)
IA, Common iliac artery; EIA, external iliac artery; SFA, superficial fem-
ral artery.
able III. TASC II classification of 101 iliac artery
hronic total occlusions
TASC II classification n
B 39 (38.6%)
C 27 (26.7%)
D 35 (34.7%)
ASC, TransAtlantic InterSociety Consensus.rrest upon transfer to a stretcher. Despite regaining a
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February 2011370 Chen et alperfusing rhythm, he later expired of presumed cardiac
etiology in the intensive care unit.
Average follow-up in this study was 20.4  18.2
months. Baseline ABI for the treated limb was on average
0.52 0.20. Mean postprocedure ABI for the treated limb
was 0.76  0.23. Mean last recorded ABI for treated limb
was 0.81  0.21, resulting in a mean lasting ABI improve-
ment of 0.33  0.26.
Primary and secondary patencies are presented in Fig 1.
Primary and secondary patency rates at 1 year were 86.1%
and 94.3%, at 2 years were 75.9% and 91.9%, and at 3 years
were 68.2% and 80.4%. Examining the loss of primary
patency, 15 failures were found on surveillance; however,
only 10 patients proceeded with a secondary intervention,
consisting of endovascular intervention (8 lesions), open
Table IV. Procedural complications during 101
subintimal angioplasties of iliac artery chronic total
occlusions
Complication n Outcomes
Femoral pseudoaneurysm 2 Treated with ultrasound-
directed thrombin injection
Groin hematoma 3 Managed by observation
Sheared sheath fragment 1 Sheath fragment removed with
endovascular snare
Retroperitoneal
hematoma
1 Underwent surgical
exploration without
identification of injury
Ruptured external iliac
artery
2 Placement of covered stent
during procedure in both
cases, 1 death
Fig 1. Primary and secondary patency of SIA of iliac artery
chronic total occlusion (CTO). Primary and secondary patency at
36 months was 68% (SE, 7.1%) and 80% (SE, 7.0%).thrombectomy (1 lesion), and subintimal channel relining mith EVAR extension limb (1 lesion). Modalities detecting
hese failures were: angiography (3), duplex ultrasound (7),
linical examination (4), and CTA (1). Examining the tertiary
rocedures, the seven completed included femoral-to-
emoral bypass (3), aortobifemoral bypasses (2), 1 aortoil-
ofemoral bypass (1), and aortoiliofemoral endarterectomy
1). In five of these lesions, loss of patency was detected by
ngiography (2) and duplex ultrasound (3). In one aorto-
ifemoral bypass and the aortoiliofemoral bypass, these
rocedures were done for abdominal aortic pathology not
oss of patency.
Survival is presented in Fig 2. Survival rate at 1, 3, and
years was 92.6%, 77.4%, and 66.5%, respectively. Free-
om from claudication is presented in Fig 3. Symptomatic
mprovement was 89.0%, 77.8%, and 72.8%, respectively at
, 2, and 3 years. Limb salvage in critical limb ischemia
atients is presented in Fig 4. Limb salvage was 97.3% at 1
ear and 94.5% at 5 years. Of the 19 patients with gangrene,
4 (73.7%) healed their wounds after intervention. Only
wo (5.4%) of the CLI patients required amputation, with
ne requiring amputation 1 month after intervention and
he other after 13 months due to infrapopliteal occlusive
isease.
The univariate analysis of factors for loss of primary
atency (Table V), revealed hyperlipidemia, coronary artery
isease, and prior surgical bypass in the treated limb to be
tatistically significant. However, on multivariate analysis,
Table VI) no factors continued to be statistically signifi-
ant though hyperlipidemia, and coronary artery disease
rended toward significance. The results were also analyzed
ith survival analysis using a log-rank test to compare
rimary patencies by TASC II classification, arterial seg-
ig 2. Survival of treated iliac artery chronic total occlusion
CTO) cohort. Survival at 60 months was 66.5% (SE, 6.2%).ent involved, sex of patient, and combined procedure
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Volume 53, Number 2 Chen et al 371status. All comparisons were not statistically significant,
likely due to inadequate power in each subgroup.
DISCUSSION
The TASC II guidelines recommend open surgery for
TASC D; however, multiple published series demonstrate
that TASC D classified iliac artery CTO can be managed
endovascularly.2,7,10,11 Most of these series utilize intralu-
Fig 3. Freedom from claudication. Freedom from claudication at
36 months was 73% (SE 7.7%).
Fig 4. Limb salvage in critical limb ischemia patients. Limb sal-
vage at 60 months was 95% (SE, 3.8%).minal techniques to traverse the iliac obstruction, with a linority of lesions managed with SIA. In this study of iliac
rtery CTO managed exclusively with SIA, 34.7% of the
esions were graded TASC D. Although a technical success
ate of 83.5% was seen in this study, the majority of these
able V. Univariate analysis of variables for loss of
rimary patency in 101 subintimal angioplasties of iliac
rtery chronic total occlusions
ariable HR 95% CI P value
ale sex 1.31 0.70-2.44 .40
ge  70 1.01 0.53-1.95 .97
ge  80 1.55 0.61-3.94 .36
bese 1.35 0.73-2.49 .34
ypertension 0.58 0.29-1.15 .12
yperlipidemia 3.80 1.35-10.65 .01
iabetes mellitus 1.09 0.59-2.00 .79
nd-stage renal disease 1.22 0.51-2.89 .66
oronary artery disease 2.28 1.17-4.46 .02
ver smoked 1.07 0.58-1.98 .82
ctively smoking 0.92 0.59-1.41 .69
hronic obstructive pulmonary
disease 0.62 0.19-2.01 .43
rior surgical bypass in treated
limb 2.34 1.03-5.30 .04
onsurgical candidate 1.42 0.68-2.97 .35
ombined SIA and outflow
procedure 1.79 0.76-4.26 .19
nilateral balloon used 1.67 0.88-3.17 .12
ntegrade subintimal
dissection 0.83 0.45-1.53 .55
tents used 1.05 0.49-2.28 .90
e-entry device used 1.00 0.42-2.37 1.00
ritical limb ischemia 1.16 0.62-2.14 .65
ommon iliac artery (CIA)
involved 0.76 0.40-1.42 .39
xternal iliac artery (EIA)
involved 1.67 0.87-3.21 .13
uperficial femoral artery
involved 0.91 0.36-2.31 .84
opliteal involved 0.68 0.09-4.94 .70
ombined CIA and EIA lesion 1.26 0.67-2.39 .47
ASC B 1.26 0.69-2.33 .46
ASC C 1.30 0.68-2.50 .43
ASC D 0.60 0.30-1.20 .15
I, Confidence interval; HR, hazard ratio; TASC, TransAtlantic InterSoci-
ty Consensus.
able VI. Multivariate analysis of risk factors for loss of
rimary patency in 101 subintimal angioplasties of iliac
rtery chronic total occlusions
ariable HR 95% CI P value
yperlipidemia 2.78 0.97-8.03 .06
oronary artery disease 1.97 0.97-3.99 .06
rior bypass in treated limb 1.80 0.77-4.21 .17
ombined SIA and outflow
procedure 1.26 0.51-3.12 .62
nilateral balloon used 1.36 0.67-2.76 .40
xternal iliac artery
involvement 1.59 0.78-3.23 .20
I, Confidence interval; HR, hazard ratio; SIA, subintimal angioplasty.esions were TASCC andD (61.4%), and all of these lesions
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February 2011372 Chen et alwere iliac artery CTOs. Technical success in revasculariza-
tion of CTOs in contemporary series has been reported
between 92% and 99%.10,11 The technical failures in this
study were all due to failed re-entry. For a portion of this
study, no re-entry device was commercially available, con-
tributing to this lower technical success rate. Additionally,
while lesions may have the same TASC classification, a
totally calcified iliac artery that can only be crossed with a
subintimal technique is not the same pathology as an
acutely thrombosed iliac artery that can be crossed in an
intraluminal fashion, so comparisons between studies based
purely on TASC classification may not be entirely valid.
In this study, 11 (11.5%) patients underwent a com-
bined approach involving an outflow procedure in conjunc-
tion with SIA of their iliac artery CTO. Some would argue
that these patients should have undergone an aortobifemo-
ral bypass instead of a combined approach, as the patient
was exposed to the physiologic stress of an open procedure.
Further examining these patients reveals that the eight of
these open procedures for these hybrid cases were endar-
terectomy and patch angioplasty, a procedure that can be
performed under local or regional anesthesia. The com-
bined approach avoids the physiologic stress of an aortic
cross-clamp that an aortobifemoral bypass requires. The
presence of outflow disease in conjunction with inflow
disease is well demonstrated by the fact that over the course
of the study, 24 (25.0%) patients would also undergo
outflow procedures, both endovascular and open, in distal
vessels.
This study demonstrates 3-year primary and secondary
patency rates of 68% and 80%. Compared with reported
aortobifemoral reconstruction patencies of 85% to 90% at 5
years, SIA for iliac artery CTOs appears to be less durable.12
Looking at other contemporary series of endovascular
treatment of iliac artery CTOs, however, reveals similar
outcomes to our study. Ozkan reported primary and sec-
ondary patencies at 5 years of 63% and 93%.10 Kondo
reported a 2-year primary patency rate of 90% for primary
stenting of iliac artery CTOs.11 Both studies do not report
the numbers at risk in their Kaplan-Meier analysis, and keep
in mind, these two studies examine different populations
from our study, likely accounting for the differences in
patency. In a similar fashion, direct comparison with aorto-
bifemoral bypass is not valid, as our practice’s aortobifemo-
ral bypass patients are now mostly a historical cohort.
Our study population had an average age of 64 and
significant comorbidity profile, as evident by the fact that
almost one-third of these patients had died by 60 months.
Additionally, nearly one-fifth were judged to be of prohib-
itively high risk for operative intervention. Nevertheless, for
these patients, this study demonstrates a procedural mor-
tality rate of only 1.0% and major procedural complication
rate of only 3.0%, with only one patient requiring manage-
ment of their complication in the operating room. Review-
ing the complications by date of procedure, the number of
complications peaked in 2005 and has been steady at one to
two per year, suggesting that there is a learning curve for Ohis technique. But this low procedural complication rate
onfirms that SIA for iliac artery CTO is a safe intervention.
There are multiple limitations to this study due to its
etrospective nature. First, over the 9 years of the study, the
echniques, equipment, and experience of the surgeons
ave changed, giving the results reported. Second, the choice
f intervention was a mutual decision between the surgeon
nd patient, reflecting the biases of both parties. Third, sur-
eons havemodified the follow-up protocol thereby affecting
urveillance results. Finally, short follow-up periods can be
ound in the database. It is not clear if these represent
atients with good response to therapy, therefore, having
o reason to return for follow-up or the opposite.
Despite these limitations, this study presents the largest
eries of iliac artery CTOs managed exclusively with SIA
nd selective stenting. The good midterm patencies and
ow procedural mortality and morbidity of SIA in the study
emonstrate the value of this technique in this patient
opulation in which one-third died by 5 years. Comparison
etween SIA and intraluminal techniques will require a
andomized prospective study to sort out the optimal tech-
ique, as the published contemporary iliac artery CTO
eries comprise foreign patient populations.
ONCLUSION
This study demonstrates that not only is SIA feasible for
liac CTO, but that it is a safe and durable option. SIA
rovides a competitive alternative to aortobifemoral recon-
truction, especially in those patients that are not candi-
ates for open revascularization. SIA also provides excellent
imb salvage and relief from claudication. With comparable
atency, yet less morbidity and mortality than open revas-
ularization, we consider SIA as a reasonable first-line op-
ion for treatment of iliac artery CTOs.
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